Variation Among Rheumatologists in the Use of Prednisone and Second-line Agents for the Treatment of Rheumatoid Arthritis
Overview
Authors
Affiliations
Objective: To test for and estimate variation among rheumatologists in their prescribing of prednisone and second-line agents for the treatment of rheumatoid arthritis (RA), after taking into account the characteristics of their patients.
Methods: Multiple logistic regression incorporating random effects for rheumatologists, with adjustment for patient characteristics.
Results: Values for the likelihood-ratio statistic provided strong evidence of such variation. Random-effect variance estimates showed that the variation is of great magnitude.
Conclusion: Even after patient characteristics have been taken into account, the data show that the rheumatologist may strongly influence the use of prednisone and second-line agents by a patient.
GLUCOCORTICOIDS IN CHRONIC DISEASE: THE GOOD, THE BAD, THE BONE.
Saag K Trans Am Clin Climatol Assoc. 2023; 133:69-80.
PMID: 37701582 PMC: 10493762.
George M, Baker J, Wallace B, Chen L, Wu Q, Xie F Arthritis Care Res (Hoboken). 2020; 73(11):1597-1605.
PMID: 32702188 PMC: 8689568. DOI: 10.1002/acr.24382.
Wallace B, Lin P, Kamdar N, Noureldin M, Hayward R, Fox D Semin Arthritis Rheum. 2019; 50(2):228-236.
PMID: 31522762 PMC: 7060094. DOI: 10.1016/j.semarthrit.2019.09.002.
Ferraz-Amaro I, Seoane-Mato D, Sanchez-Alonso F, Martin-Martinez M Rheumatol Int. 2015; 35(11):1825-36.
PMID: 26403284 DOI: 10.1007/s00296-015-3363-5.
A brief history of medical taxonomy and diagnosis.
Balint G, Buchanan W, Dequeker J Clin Rheumatol. 2006; 25(2):132-5.
PMID: 16453080 DOI: 10.1007/s10067-004-1051-z.